BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36509123)

  • 1. Generalizability of Risk Stratification Algorithms for Exacerbations in COPD.
    Ho JK; Safari A; Adibi A; Sin DD; Johnson K; Sadatsafavi M;
    Chest; 2023 Apr; 163(4):790-798. PubMed ID: 36509123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACCEPT 2·0: Recalibrating and externally validating the Acute COPD exacerbation prediction tool (ACCEPT).
    Safari A; Adibi A; Sin DD; Lee TY; Ho JK; Sadatsafavi M
    EClinicalMedicine; 2022 Sep; 51():101574. PubMed ID: 35898315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical prediction model for hospitalized COPD exacerbations based on "treatable traits".
    Yii ACA; Loh CH; Tiew PY; Xu H; Taha AAM; Koh J; Tan J; Lapperre TS; Anzueto A; Tee AKH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():719-728. PubMed ID: 30988606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study.
    Adibi A; Sin DD; Safari A; Johnson KM; Aaron SD; FitzGerald JM; Sadatsafavi M
    Lancet Respir Med; 2020 Oct; 8(10):1013-1021. PubMed ID: 32178776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a New Risk Measure for Chronic Obstructive Pulmonary Disease Exacerbation Using Health Insurance Claims Data.
    Stanford RH; Nag A; Mapel DW; Lee TA; Rosiello R; Vekeman F; Gauthier-Loiselle M; Duh MS; Merrigan JF; Schatz M
    Ann Am Thorac Soc; 2016 Jul; 13(7):1067-75. PubMed ID: 27070274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A score to predict short-term risk of COPD exacerbations (SCOPEX).
    Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between risk, cumulative burden of exacerbations and mortality in patients with COPD: modelling analysis using data from the ETHOS study.
    Rhodes K; Jenkins M; de Nigris E; Aurivillius M; Ouwens M
    BMC Med Res Methodol; 2022 May; 22(1):150. PubMed ID: 35614467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Severe Chronic Obstructive Pulmonary Disease Exacerbations. Developing a Population Surveillance Approach with Administrative Data.
    Tavakoli H; Chen W; Sin DD; FitzGerald JM; Sadatsafavi M
    Ann Am Thorac Soc; 2020 Sep; 17(9):1069-1076. PubMed ID: 32383971
    [No Abstract]   [Full Text] [Related]  

  • 9. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
    Herath SC; Normansell R; Maisey S; Poole P
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009764. PubMed ID: 30376188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD): Report of the Third COPD Modeling Meeting.
    Hoogendoorn M; Feenstra TL; Asukai Y; Briggs AH; Hansen RN; Leidl R; Risebrough N; Samyshkin Y; Wacker M; Rutten-van Mölken MP
    Value Health; 2017 Mar; 20(3):397-403. PubMed ID: 28292484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Guideline-Recommended COPD Inhaler Regimens With Mortality, Respiratory Exacerbations, and Quality of Life: A Secondary Analysis of the Long-Term Oxygen Treatment Trial.
    Keller T; Spece LJ; Donovan LM; Udris E; Coggeshall SS; Griffith M; Bryant AD; Casaburi R; Cooper JA; Criner GJ; Diaz PT; Fuhlbrigge AL; Gay SE; Kanner RE; Martinez FJ; Panos RJ; Shade D; Sternberg A; Stibolt T; Stoller JK; Tonascia J; Wise R; Yusen RD; Au DH; Feemster LC
    Chest; 2020 Aug; 158(2):529-538. PubMed ID: 32278779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
    Vollenweider DJ; Frei A; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010257. PubMed ID: 30371937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing a Machine Learning Model to Predict Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study.
    Zeng S; Arjomandi M; Tong Y; Liao ZC; Luo G
    J Med Internet Res; 2022 Jan; 24(1):e28953. PubMed ID: 34989686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic non-invasive ventilation for chronic obstructive pulmonary disease.
    Raveling T; Vonk J; Struik FM; Goldstein R; Kerstjens HA; Wijkstra PJ; Duiverman ML
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD002878. PubMed ID: 34368950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis.
    Oba Y; Keeney E; Ghatehorde N; Dias S
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012620. PubMed ID: 30521694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive modeling of COPD exacerbation rates using baseline risk factors.
    Singh D; Hurst JR; Martinez FJ; Rabe KF; Bafadhel M; Jenkins M; Salazar D; Dorinsky P; Darken P
    Ther Adv Respir Dis; 2022; 16():17534666221107314. PubMed ID: 35815359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-IL-5 therapies for chronic obstructive pulmonary disease.
    Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exacerbations in Chronic Obstructive Pulmonary Disease: Identification and Prediction Using a Digital Health System.
    Shah SA; Velardo C; Farmer A; Tarassenko L
    J Med Internet Res; 2017 Mar; 19(3):e69. PubMed ID: 28270380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
    Suh DC; Lau H; La HO; Choi IS; Geba GP
    Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.